Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- REGULATORY NEWS IN BRIEF
June 25, 2007
- OPINION：Be the First to Know
June 25, 2007
- Smoking Rate Drops Below 40% in Men for First Time
June 25, 2007
- 43rd ASCO Annual Meeting in Chicago(1)
June 25, 2007
- Eisai Licenses Kissei's Glufast in ASEAN Countries
June 25, 2007
- 43rd ASCO Annual Meeting in Chicago(2)
June 25, 2007
- Yakult Aims for \33 Bil. Sales by Boosting Sales of Oxaliplatin
June 25, 2007
- e-IND Studies Useful but Problems Need to Be Solved: Symposium
June 25, 2007
- Kirin Aims at 50% Market Share with Nesp
June 25, 2007
- AMG0001's Efficacy for CLI Confirmed in PIII: AnGes MG
June 25, 2007
- Zetia Expands Options for Dyslipidemia with New Mechanism of Action: Schering-Plough, Bayer
June 25, 2007
- Takeda, Archemix Tie Up for Aptamer Therapeutics
June 25, 2007
- Pfizer Japan Invites 600 Employees to Retire
June 25, 2007
- R&D NEWS IN BRIEF
June 25, 2007
- JPMA Members Should Not Depend on Long-Listed Drugs: President Aoki
June 25, 2007
- JGPMA Proposes “Drug Benefit Standard Price” System
June 25, 2007
- Pfizer Most Active in GP Market: MOSS Survey
June 25, 2007
- GENERIC NEWS IN BRIEF
June 25, 2007
- BUSINESS NEWS IN BRIEF
June 25, 2007
- MEDICAL DEVICE NEWS IN BRIEF
June 25, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…